Scleroderma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
| (14 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Scleroderma}} | {{Scleroderma}} | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{MKA}} {{CZ}} | |||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | |||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{SK}} Systemic sclerosis | {{SK}} Systemic sclerosis; CREST syndrome; limited scleroderma; progressive systemic sclerosis; localized scleroderma; mixed connective disease; morphea - linear; sclerosis, systemic; systemic scleroderma | ||
===Click [[The Heart in Progressive Systemic Sclerosis (Scleroderma)|here]] for The Heart in Scleroderma=== | ===Click [[The Heart in Progressive Systemic Sclerosis (Scleroderma)|here]] for The Heart in Scleroderma=== | ||
==[[Scleroderma overview|Overview]]== | ==[[Scleroderma overview|Overview]]== | ||
| Line 33: | Line 19: | ||
==[[Scleroderma causes|Causes]]== | ==[[Scleroderma causes|Causes]]== | ||
==[[Scleroderma | ==[[Differentiating Scleroderma from other diseases|Differentiating Scleroderma from other Diseases]]== | ||
==[[Scleroderma epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Scleroderma epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Scleroderma risk factors|Risk Factors]]== | ==[[Scleroderma risk factors|Risk Factors]]== | ||
==[[Scleroderma screening|Screening]]== | |||
==[[Scleroderma natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Scleroderma natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[Scleroderma history and symptoms|History and Symptoms]] | [[Scleroderma physical examination|Physical Examination]] | [[Scleroderma laboratory findings|Laboratory Findings]] | [[Scleroderma diagnostic study of choice|Diagnostic Study of Choice]] | [[Scleroderma history and symptoms|History and Symptoms]] | [[Scleroderma physical examination|Physical Examination]] | [[Scleroderma laboratory findings|Laboratory Findings]] | [[Scleroderma electrocardiogram|Electrocardiogram]] | [[Scleroderma x ray|X Ray]] | [[Scleroderma CT|CT]] | [[Scleroderma MRI|MRI]] | [[Scleroderma echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Scleroderma other imaging findings|Other Imaging Findings]] | [[Scleroderma other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Scleroderma medical therapy|Medical Therapy]] | [[Scleroderma surgery|Surgery]] | [[Scleroderma primary prevention|Primary Prevention]] | [[Scleroderma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Scleroderma future or investigational therapies|Future or Investigational Therapies]] | [[Scleroderma medical therapy|Medical Therapy]] | [[Scleroderma surgery|Surgery]] | [[Scleroderma primary prevention|Primary Prevention]] | [[Scleroderma secondary prevention|Secondary Prevention]] | [[Scleroderma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Scleroderma future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
| Line 52: | Line 40: | ||
{{Diseases of the musculoskeletal system and connective tissue}} | {{Diseases of the musculoskeletal system and connective tissue}} | ||
[[de:Sklerodermie]] | [[de:Sklerodermie]] | ||
[[fr:Sclérodermie]] | [[fr:Sclérodermie]] | ||
| Line 73: | Line 55: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Autoimmune diseases]] | |||
[[Category:Diseases involving the fasciae]] | |||
[[Category:Rheumatology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Medicine]] | |||
[[Category:Dermatology]] | |||
Latest revision as of 00:05, 30 July 2020
|
Scleroderma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Scleroderma On the Web |
|
American Roentgen Ray Society Images of Scleroderma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: M. Khurram Afzal, MD [2] Cafer Zorkun, M.D., Ph.D. [3]
For patient information click here
Synonyms and keywords: Systemic sclerosis; CREST syndrome; limited scleroderma; progressive systemic sclerosis; localized scleroderma; mixed connective disease; morphea - linear; sclerosis, systemic; systemic scleroderma
Click here for The Heart in Scleroderma
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Scleroderma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Template:Diseases of the musculoskeletal system and connective tissue
de:Sklerodermie
it:Sclerodermia
he:סקלרודרמה
nl:Sclerodermie
sk:Sklerodermia
sv:Sklerodermi